Indications and uses
• relieves occasional constipation (irregularity) • generally produces bowel movement in 6 to 12 hours
• relieves occasional constipation (irregularity) • generally produces bowel movement in 6 to 12 hours
• swallow tablet(s) with a glass of water • swallow tablet(s) whole, do not crush, break or chew adults and children 12 years of age and older 2 tablets once or twice daily children 6 to under 12 years of age 1 tablet once or twice daily children under 6 years of age ask a doctor
Sennosides 25 mg
Stimulant laxative
laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor
noticed a sudden change in bowel habits that persists over a period of 2 weeks
taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.
do not use for a period longer than 1 week
rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
adults and children 12 years of age and older | 2 tablets once or twice daily |
children 6 to under 12 years of age | 1 tablet once or twice daily |
children under 6 years of age | ask a doctor |
acacia, calcium carbonate, carnauba wax, corn starch dibasic calcium phosphate, FD&C blue no.1 aluminum lake, iron oxide black, magnesium stearate, methyl paraben, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, propylene glycol, propylparaben, shellac, silicon dioxide, sodium benzoate, sodium lauryl sulfate, sucrose, talc, titanium dioxide
call 1-855-221-5432
The Ex•Lax® Guarantee: When taken as directed, Ex•Lax® is guaranteed to work gently and effectively overnight or your money back. Return product to GSK, attention Consumer Affairs, for full refund.
Tamper Evident Feature: Ex•Lax® Tablets are sealed in blister packets. Use only if the individual seal is unbroken.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 213073 | Ex-Lax Maximum Strength 25 MG Oral Tablet | PSN | 6 |
| 251292 | sennosides 25 MG Oral Tablet | PSN | 6 |
| 213073 | sennosides, USP 25 MG Oral Tablet [Ex-Lax Maximum Relief Formula] | SBD | 6 |
| 251292 | sennosides, USP 25 MG Oral Tablet | SCD | 6 |
| 213073 | Ex-Lax Maximum Relief Formula 25 MG Oral Tablet | SY | 6 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0067-8142-01 | EX-LAXMAXIMUM STRENGTH STIMULANT LAXATIVE | 12 in 1 BLISTER PACK | PILL | 12 | 6 | |
| 0067-8142-01 | EX-LAXMAXIMUM STRENGTH STIMULANT LAXATIVE | 2 in 1 CARTON | PILL | 2 | 6 | |
| 0067-8142-02 | EX-LAXMAXIMUM STRENGTH STIMULANT LAXATIVE | 12 in 1 BLISTER PACK | PILL | 12 | 6 | |
| 0067-8142-02 | EX-LAXMAXIMUM STRENGTH STIMULANT LAXATIVE | 4 in 1 CARTON | PILL | 4 | 6 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0067-8142-01 | EA - Each | 0067-8142 | ff3c59f3-197f-4ec3-af8b-e9e43ff9918e | 1 | 2022-10-06 |
| 0067-8142-02 | EA - Each | 0067-8142 | f206bb4d-db09-42d0-83ff-549032b29f6e | 1 | 2024-11-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0067-8142 | 0067-8142-01, 0067-8142-02 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EX-LAX MAXIMUM STRENGTH STIMULANT LAXATIVE | SENNOSIDES | Haleon US Holdings LLC | fb170340-c996-46cf-b165-84e136ba4151 | 2024-12-17 | Warnings | 0067-8142-02 0067-8142-01 0067-8142 00067814201 00067814202 2133e636-8bf8-4e31-b653-1ea9dc773e7e fb170340-c996-46cf-b165-84e136ba4151 |
Adverse event summaries are temporarily unavailable. Other product information remains available.